Danimer Scientific, Inc. (DNMR)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Danimer Scientific, Inc. (DNMR) with AI Score 44/100 (Weak). Danimer Scientific, Inc. develops and produces bioplastic replacements for traditional petroleum-based plastics. Market cap: 0, Sector: Basic materials.
Last analyzed: Mar 16, 2026Danimer Scientific, Inc. (DNMR) Materials & Commodity Exposure
Danimer Scientific, Inc. specializes in developing and producing biodegradable plastic alternatives, primarily polyhydroxyalkanoate (PHA) under the Nodax brand. Targeting consumer packaging and plastics industries, the company offers sustainable solutions to replace traditional petroleum-based plastics, addressing growing environmental concerns and regulatory pressures.
Investment Thesis
Danimer Scientific presents an investment opportunity within the burgeoning bioplastics market, driven by increasing consumer demand for sustainable packaging and stricter environmental regulations. The company's Nodax PHA offers a biodegradable alternative to traditional plastics, potentially capturing market share as brands seek eco-friendly solutions. However, current financials reveal a negative profit margin of -333.0% and a negative gross margin of -57.7%, indicating significant challenges in achieving profitability. The company's success hinges on scaling production efficiently, securing key partnerships with major consumer brands, and navigating the competitive landscape of bioplastic producers. Investors should closely monitor the company's progress in improving margins and achieving sustainable revenue growth.
Based on FMP financials and quantitative analysis
Key Highlights
- Danimer Scientific operates in the bioplastics market, addressing the increasing demand for sustainable alternatives to traditional petroleum-based plastics.
- The company's core product, Nodax PHA, is a biodegradable plastic feedstock used in various applications, including films, straws, and food containers.
- Danimer Scientific serves consumer packaging brand owners, converters, and manufacturers in the plastics industry.
- The company's negative profit margin of -333.0% and gross margin of -57.7% highlight the current challenges in achieving profitability.
- Danimer Scientific's beta of 1.63 suggests higher volatility compared to the overall market.
Competitors & Peers
Strengths
- Proprietary Nodax PHA technology.
- Focus on biodegradable and sustainable materials.
- Potential for strong growth in the bioplastics market.
- Established relationships with consumer packaging companies.
Weaknesses
- Negative profit and gross margins.
- Limited production capacity compared to larger competitors.
- Reliance on a few key customers.
- Higher production costs compared to traditional plastics.
Catalysts
- Ongoing: Increasing consumer demand for sustainable packaging solutions.
- Ongoing: Government regulations promoting the use of bioplastics.
- Upcoming: Potential partnerships with major consumer brands to adopt Nodax PHA.
- Ongoing: Expansion of production capacity to meet growing demand.
- Ongoing: Development of new applications for PHA in various industries.
Risks
- Ongoing: Negative profit and gross margins indicating financial instability.
- Potential: Competition from established chemical companies with greater resources.
- Potential: Fluctuations in raw material prices impacting production costs.
- Potential: Technological advancements in alternative materials.
- Potential: Limited liquidity due to trading on the OTC market.
Growth Opportunities
- Growth opportunity 1: Expanding Production Capacity: Danimer Scientific can increase its market share by expanding its production capacity to meet the growing demand for PHA. Investing in new manufacturing facilities and optimizing existing processes will enable the company to fulfill larger orders and secure long-term contracts with major consumer brands. The bioplastics market is projected to reach $29.7 billion by 2025, providing a substantial opportunity for Danimer Scientific to capitalize on increased production capabilities.
- Growth opportunity 2: Strategic Partnerships: Forming strategic partnerships with consumer packaging companies and manufacturers can accelerate the adoption of Nodax PHA. Collaborating with established players in the plastics industry will provide Danimer Scientific with access to existing distribution channels and customer networks. These partnerships can also facilitate the development of new applications for PHA and drive innovation in sustainable packaging solutions. Timeline: Ongoing.
- Growth opportunity 3: New Product Development: Investing in research and development to create new biopolymer formulations and applications can differentiate Danimer Scientific from its competitors. Developing PHA-based solutions for specific industries, such as agriculture or healthcare, can open up new market segments and revenue streams. Focusing on developing high-performance bioplastics with enhanced properties will further strengthen the company's competitive advantage. Timeline: Ongoing.
- Growth opportunity 4: Government Incentives and Regulations: Capitalizing on government incentives and regulations that promote the use of bioplastics can drive demand for Danimer Scientific's products. Many countries are implementing policies to reduce plastic waste and encourage the adoption of sustainable alternatives. By actively engaging with policymakers and participating in industry initiatives, Danimer Scientific can benefit from these favorable regulatory trends. Timeline: Ongoing.
- Growth opportunity 5: Global Expansion: Expanding into new geographic markets can diversify Danimer Scientific's revenue base and reduce its reliance on the North American market. Targeting regions with strong environmental awareness and supportive government policies, such as Europe and Asia, can provide significant growth opportunities. Establishing local partnerships and distribution networks in these regions will facilitate market entry and ensure long-term success. Timeline: Ongoing.
Opportunities
- Expanding production capacity to meet growing demand.
- Forming strategic partnerships with major consumer brands.
- Developing new applications for PHA in various industries.
- Benefiting from government incentives and regulations promoting bioplastics.
Threats
- Competition from established chemical companies.
- Fluctuations in raw material prices.
- Technological advancements in alternative materials.
- Economic downturns affecting consumer spending.
Competitive Advantages
- Proprietary Nodax PHA technology offers a biodegradable alternative to traditional plastics.
- Focus on sustainable bioplastic solutions aligns with growing environmental concerns.
- Established relationships with consumer packaging companies.
- Potential for economies of scale as production volume increases.
About DNMR
Founded in 2004 and headquartered in Bainbridge, Georgia, Danimer Scientific, Inc. is a performance polymer company focused on creating sustainable bioplastic replacements for conventional petroleum-based plastics. The company's core product is polyhydroxyalkanoate (PHA), a biodegradable plastic feedstock alternative marketed under the Nodax brand. This material is utilized in a wide array of plastic applications, including films, straws, food containers, and other packaging solutions. In addition to PHA, Danimer Scientific also produces polylactic acid-based resins for coating disposable paper cups and other biopolymers. The company offers its biopolymers in various forms, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. Danimer Scientific markets its products directly to consumer packaging brand owners, converters, and manufacturers within the plastics industry, positioning itself as a key player in the growing market for sustainable and biodegradable plastic alternatives.
What They Do
- Develops bioplastic replacements for traditional petroleum-based plastics.
- Produces polyhydroxyalkanoate (PHA) under the Nodax brand.
- Offers PHA for various plastic applications like films, straws, and food containers.
- Produces polylactic acid-based resins for coating disposable paper cups.
- Provides biopolymers in forms like additives, coatings, fibers, and films.
- Markets products to consumer packaging brand owners and manufacturers.
Business Model
- Develops and manufactures bioplastic materials.
- Sells biopolymers to consumer packaging companies.
- Generates revenue through direct sales and partnerships.
- Focuses on sustainable and biodegradable plastic alternatives.
Industry Context
Danimer Scientific operates within the specialty chemicals industry, specifically targeting the bioplastics market. This market is driven by increasing consumer awareness of environmental issues and stricter regulations on single-use plastics. The competitive landscape includes companies like CDELF, ETUGF, GFTRF, GSPI, and HANCF, each offering various bioplastic solutions. The demand for biodegradable and compostable materials is expected to grow, creating opportunities for companies like Danimer Scientific to expand their market share by offering innovative and cost-effective bioplastic alternatives.
Key Customers
- Consumer packaging brand owners seeking sustainable materials.
- Converters who transform raw materials into finished products.
- Manufacturers in the plastics industry looking for bioplastic alternatives.
Financials
Chart & Info
Danimer Scientific, Inc. (DNMR) stock price: Price data unavailable
Latest News
-
Earnings Scheduled For November 14, 2024
benzinga · Nov 14, 2024
-
Earnings Scheduled For November 14, 2023
benzinga · Nov 14, 2023
-
Stocks That Hit 52-Week Lows On Monday
benzinga · Dec 12, 2022
-
Stocks That Hit 52-Week Lows On Monday
benzinga · Oct 24, 2022
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DNMR.
Price Targets
Wall Street price target analysis for DNMR.
MoonshotScore
What does this score mean?
The MoonshotScore rates DNMR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Richard N. Altice
CEO
Richard N. Altice serves as the CEO of Danimer Scientific, Inc. His background includes extensive experience in the chemicals and plastics industries. He has held various leadership positions in both public and private companies, focusing on strategic planning, business development, and operational efficiency. Altice's expertise lies in driving growth and innovation within the sustainable materials sector. His leadership is crucial for Danimer Scientific as the company navigates the evolving bioplastics market.
Track Record: Under Richard N. Altice's leadership, Danimer Scientific has focused on expanding its production capabilities and forging partnerships with key players in the consumer packaging industry. He has overseen the commercialization of Nodax PHA and its adoption in various applications. A key milestone has been navigating the company through a challenging financial period while maintaining focus on long-term growth and sustainability goals.
DNMR OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Danimer Scientific may not meet the minimum financial or reporting standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as those listed on major exchanges like NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing due to lack of transparency.
- Low trading volume can lead to price volatility and difficulty in executing trades.
- OTC Other tier companies may be subject to less regulatory oversight.
- Potential for fraud or manipulation is higher in the OTC market.
- Limited access to company information and management.
- Verify the company's registration and legal standing.
- Attempt to obtain any available financial statements, even if unaudited.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC securities.
- Consult with a financial advisor before making any investment decisions.
- Check for any regulatory actions or legal disputes involving the company.
- Company has a functional website with contact information.
- Company has been in operation for a reasonable period of time (founded in 2004).
- Company has a physical headquarters in Bainbridge, Georgia.
- Company has a stated business purpose and target market.
- Company has a CEO and management team.
Danimer Scientific, Inc. Stock: Key Questions Answered
What does Danimer Scientific, Inc. do?
Danimer Scientific, Inc. specializes in the development and production of biodegradable plastic alternatives, primarily polyhydroxyalkanoate (PHA) under the Nodax brand. The company provides sustainable solutions to replace traditional petroleum-based plastics, targeting consumer packaging and plastics industries. Their products are used in various applications, including films, straws, food containers, and coatings for disposable paper cups, addressing the growing demand for eco-friendly materials.
What do analysts say about DNMR stock?
AI analysis is currently pending for DNMR. Given the company's financials, analysts are likely to focus on its path to profitability, revenue growth, and ability to scale production efficiently. Key valuation metrics to watch include revenue multiples and comparisons to peers in the bioplastics industry. The company's success hinges on securing partnerships with major consumer brands and navigating the competitive landscape.
What are the main risks for DNMR?
The main risks for Danimer Scientific include its current negative profit and gross margins, indicating financial instability. Competition from established chemical companies with greater resources poses a significant threat. Fluctuations in raw material prices can impact production costs, and technological advancements in alternative materials could erode the company's competitive advantage. Additionally, trading on the OTC market presents liquidity risks.
What are the key factors to evaluate for DNMR?
Danimer Scientific, Inc. (DNMR) currently holds an AI score of 44/100, indicating low score. Key strength: Proprietary Nodax PHA technology.. Primary risk to monitor: Ongoing: Negative profit and gross margins indicating financial instability.. This is not financial advice.
How frequently does DNMR data refresh on this page?
DNMR prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven DNMR's recent stock price performance?
Recent price movement in Danimer Scientific, Inc. (DNMR) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary Nodax PHA technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider DNMR overvalued or undervalued right now?
Determining whether Danimer Scientific, Inc. (DNMR) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying DNMR?
Before investing in Danimer Scientific, Inc. (DNMR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited and subject to change.